Compartilhar
Informação da revista
Compartilhar
Compartilhar
Baixar PDF
Mais opções do artigo
Visitas
104
Scientific Comment
DOI: 10.1016/j.htct.2018.01.004
Age and cytogenetic abnormalities
Visitas
104
Cármino Antonio de Souza
Autor para correspondência
carmino@unicamp.br

Correspondence to: Universidade Estadual de Campinas (UNICAMP), Rua Carlos Chagas, 450 Cidade Universitária “Prof. Zeferino Vaz” Distrito de Barão Geraldo, Campinas, SP, Brazil.
Universidade Estadual de Campinas (Unicamp), Campinas, SP, Brazil
Conteúdo relacionado
10.1016/j.htct.2017.10.001
Angelica de Souza Batista Maia Alves, Fernanda Barbi Bataglia, Luciene de Oliveira Conterno, Rosimeire Segato, Spencer Luiz Marques Payão
Este item recebeu
104
Visitas
Informação do artigo
Texto Completo
Bibliografia
Baixar PDF
Estatísticas
Texto Completo

In this issue, the Hematology, Transfusion and Cell Therapy Journal is publishing a paper of Alves et al. coordinated by Dr. Payão from the Medical School of Marilia, São Paulo, Brazil, discussing an interesting aspect of cytogenetic abnormalities (CA) in respect to aging. In a retrospective analysis of a large sample (746 patients) over 18 years of observation and including several types of onco-hematological diseases in patients of all ages, the authors investigated the influence of age on the frequency of CA.1 The authors found a higher frequency of hematological malignancies among elderly patients, about 51%, followed by adult (38%) and young patients (about of 11%). The authors reported that “it is possible to conclude that failures in genomic mechanisms and hematopoiesis with aging lead to the formation of cells with the chromosomal alterations found in hematological malignancies”. From the 1960s with the description of Philadelphia chromosome in chronic myeloid leukemia (CML),2 CA have been recognized as important prognostic factors in acute promyelocytic leukemia (APL), acute myeloid leukemia (AML), myelodysplastic syndromes (MDS) and in a great number of onco-hematological diseases and syndromes.3 These abnormalities became diagnostic and prognostic markers and they are very useful in the monitoring of minimal residual disease (MDR). Data from the literature supports the higher frequency of onco-hematological diseases in the elderly population.4 Particularly in AML, elderly patients have a poor prognosis compared to young and adult patients, despite the development of different therapeutic approaches. The authors emphasize that the higher aggressiveness in the elderly is probably due to bone marrow and immune system impairment. Genomic and somatic mutations, inadequate cytokine production, and impairment of modulation and response to stimuli are among the factors associated with age.5 The paper by Alves et al. presents very interesting data and discussion about the influence and mechanisms associated to frequency, gender, diagnosis and prognosis of onco-hematological diseases and aging.1 Moreover, we can see the most frequent CA observed by the authors in a single Brazilian University Laboratory.

Conflicts of interest

The authors declare no conflicts of interest.

References
[1]
A.S. Alves,F.B. Bataglia,L.O. Conterno,R. Segato,S.L. Payão
Epidemiological and cytogenetic profiles of patients with hematological malignancies and their relationship with aging
Hematol Transfus Cell Ther, (2018), http://dx.doi.org/10.1016/j.htct.2017.10.001
[2]
P.C. Nowell
Discovery of the Philadelphia chromosome: a personal perspective
J Clin Invest, 117 (2007), pp. 2033-2035 http://dx.doi.org/10.1172/JCI31771
[3]
D.A. Arber,A. Orazi,R. Hasserjian,J. Thiele,M.J. Borowitz,M.M. Le Beau
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
[4]
C.C. Laurie,C.A. Laurie,K. Rice,K.F. Doheny,L.R. Zelnick,C.P. McHugh
Detectable clonal mosaicism from birth to old age and its relationship to cancer
Nat Genet, 44 (2012), pp. 642-650 http://dx.doi.org/10.1038/ng.2271
[5]
E. Sahin,R.A. Depinho
Linking functional decline of telomeres, mitochondria and stem cells during ageing
Nature, 464 (2010), pp. 520-528 http://dx.doi.org/10.1038/nature08982

See paper by Angelica de Souza Batista Maia Alves et al. on pages [XX–XX].

Copyright © 2018. Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular
Idiomas
Revista Brasileira de Hematologia e Hemoterapia

Receba nossa Newsletter

Opções de artigo
Ferramentas
Política de cookies
Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos?